In vitro and in vivo anti-inflammatory activity of Tetrastigma sulcatum leaf extract, pure compound and its derivatives
- 22.01.2022
- Original Article
- Verfasst von
-
Ravindra Jagannath Waghole
Ravindra Jagannath Waghole
- Bioprospecting Group, Agharkar Research Institute, 411004, Pune, India
-
Ashwini Vivek Misar
Ashwini Vivek Misar
- Bioprospecting Group, Agharkar Research Institute, 411004, Pune, India
-
Neha Shashikant Kulkarni
Neha Shashikant Kulkarni
- Nanobioscience Group, Agharkar Research Institute, 411004, Pune, India
-
Feroz Khan
Feroz Khan
- Metabolic and Structural Biology Department, CSIR-CIMAP, 226015, Lucknow, India
-
Dattatraya Gopal Naik
Dattatraya Gopal Naik
- Maharashtra Education Society, C/O Biodiversity Department, Abasaheb Garware College, 411004, Pune, India
-
Sachin Hanmant Jadhav
Korrespondierender Autor Sachin Hanmant Jadhav
- Nanobioscience Group, Agharkar Research Institute, 411004, Pune, India
- Erschienen in
- Inflammopharmacology | Ausgabe 1/2022
Abstract
The severity and perseverance of inflammation have been demonstrated in many health conditions. The limitations of existing medications suggest the need for new alternative anti-inflammatory medications. In our earlier studies, we demonstrated the topical anti-inflammatory potential of the crude ethanolic extract of Tetrastigma sulcatum leaves and its fractions. In the present study, we further explored the anti-inflammatory activity of T. sulcatum extract, fractions, pure compound and its derivatives using in vitro and in vivo bioassay techniques. We attempted to isolate a pure compound from the leaf extract and identified it as a Friedelan-3β-ol (CI). Furthermore, Friedelinol acetate (C II) and friedelinol methyl ether (C III), derivatives of Friedelan-3β-ol (CI) were synthesised. LPS-induced inflammatory RAW 264.7 macrophages were used as in vitro model to study anti-inflammatory and anti-oxidative effects. Inflammation-induced oxidative damage was found to be restricted significantly (P < 0.001), with scavenging activity and increased SOD activity of crude extract and fractions. Treatment with crude extract (TSETOH) and fractions (TSHEX, TSTOL) significantly reduced (P < 0.001) the mRNA expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and nitric oxide (NO) production in LPS-stimulated inflammation in RAW 264.7 cells in a dose-dependent manner. Likewise, compounds CI and CIII showed a similar pattern of significant inhibition (P < 0.001) of pro-inflammatory cytokines and NO production in a dose-dependent manner. An in vivo study in a carrageenan-induced mouse paw oedema model demonstrated reduced paw oedema and pro-inflammatory cytokines in a dose-dependent manner upon treatment with the extract, its fractions, pure compound (CI), and their derivatives (CII, and CIII). The present study confirmed the anti-inflammatory activity of T. sulcatum, suggesting that Friedelan-3β-ol is an active component of the crude extract.
Anzeige
- Titel
- In vitro and in vivo anti-inflammatory activity of Tetrastigma sulcatum leaf extract, pure compound and its derivatives
- Verfasst von
-
Ravindra Jagannath Waghole
Ashwini Vivek Misar
Neha Shashikant Kulkarni
Feroz Khan
Dattatraya Gopal Naik
Sachin Hanmant Jadhav
- Publikationsdatum
- 22.01.2022
- Verlag
- Springer International Publishing
- Erschienen in
-
Inflammopharmacology / Ausgabe 1/2022
Print ISSN: 0925-4692
Elektronische ISSN: 1568-5608 - DOI
- https://doi.org/10.1007/s10787-021-00897-6
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.
Dieser Inhalt ist nur sichtbar, wenn du eingeloggt bist und die entsprechende Berechtigung hast.